Marksans Pharma MARKSANS.NS · INR

Its shares trade on NSE under the ticker MARKSANS.NS. It has been listed since 3 April 2002. In the fiscal year to 31 March 2025, it reported revenue of ₹26.23bn and net income of ₹3.81bn. At that date it held total assets of ₹32.40bn and shareholders' equity of ₹24.67bn.

Marksans Pharma Ltd. engages in the research, manufacture, marketing, and sale of pharmaceutical formulations. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2002-04-03. The firm is primarily engaged in the business of research, manufacture, marketing and sale of pharmaceutical formulations. The firm produces goods across various therapeutic areas, such as pain management, cough and cold, cardiovascular and central nervous system, anti-diabetic, gastrointestinal, hormonal treatment, and anti-allergic, among others. The firm operates four manufacturing facilities across India, the United Kingdom and the United States. The firm manufactures oral solid tablets, soft gelatin capsules and hard capsules in Goa. The company also manufactures non-sterile liquids, ointments and powder products and caters to the United Kingdom, West Africa and the Middle East, which is located in the United Kingdom. The firm has spread its facility to over 7000 square meters and manufactures tablets and capsules in the United States.

Figures and description from our data supplier, not checked against the company's own report.

• Mr. Mark SaldanhaExecutive Chairman of the Board, Managing Director₹68.9m
• Mr. Jitendra SharmaGroup Chief Financial Officer
• Mr. Harshavardhan PanigrahiCompany Secretary, Compliance Officer
• Mr. Sathish KumarManaging Director - UK Operations
• Mr. David MohammedManaging Director - Australia Operations
• Mr. Varddhman JainWhole Time Director, since 2019₹18.7m
• Mrs. Sandra SaldanhaWhole Time Director, since 2014₹7.1m
• Mr. Anjani KumarChief Operating Officer - US Operations
• Dr. Sunny SharmaNon-Executive and Non-Independent Director
• Mr. Seetharama BuddharajuNon-Executive Independent Director₹25,000
• Mr. Abhinna MohantyNon-Executive Independent Director₹15,000
• Mr. Digant ParikhNon-Executive Independent Director₹400,000

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.